Bio-Techne has announced an expansion of the longstanding partnership between its spatial biology brand, Advanced Cell Diagnostics (ACD), and Leica Biosystems.
The expanded spatial multiomic collaboration now includes automation of ACD's new RNAscope Multiomic LS Assay and protease-free workflows on Leica's BOND RX research staining instrument, further advancing the capabilities of spatial biology research.
The RNAscope Multiomic LS Assay enables simultaneous fluorescent detection of up to six RNA and/or protein biomarkers on the same slide, preserving RNA and protein integrity while maintaining tissue morphology. Additionally, ACD introduced a protease-free workflow for RNAscope 2.5 single-plex assays on the Leica BOND RX staining instrument, further advancing multiomic visualisation from discovery research to translational applications.
"The automation of Bio-Techne's innovative RNAscope protease-free assays on the Leica BOND RX platform marks a significant milestone in spatial multiomics research," said Dr Matt McManus, President of Bio-Techne's Diagnostics and Spatial Biology Segment. "High-precision visualisation of RNA and protein biomarkers on the same slide empowers researchers with a streamlined, fully automated solution that preserves sample integrity and accelerates scientific discoveries in translational and clinical research."
The RNAscope in situ spatial assays have been widely adopted by top academic institutions, pharmaceutical companies, and service providers worldwide, contributing to over 12,000 peer-reviewed publications. This expansion builds on the strong partnership between Bio-Techne and Leica Biosystems, established in 2015, to deliver automated in-situ hybridisation (ISH) workflows that streamline spatial biology research.
To learn more about Bio-Techne's in-situ spatial assays automated on the BOND RX research staining instrument, visit: https://www.leicabiosystems.com/us/life-sciences-and-research-solutions/partners/acd/.